QCOR News 87.06 05/14/2014 05:24:34 Questcor Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Questcor Pharmaceuticals (QCOR) 87.06 $QCOR

Post Earnings Update: Questcor Pharmaceuticals Has Climbed 10.5% Higher in Past 2 Weeks (QCOR)
Comtex SmarTrend(R) - Mon May 12, 11:42AM CDT
When Questcor Pharmaceuticals (NASDAQ:QCOR) reported earnings 14 days ago on April 28th, 2014, analysts, on average, expected the company to report earnings of $1.61 on sales of $240.8 million. Questcor Pharmaceuticals actually reported earnings of $1.51 per share on sales of $227.1 million, missing EPS estimates by $0.10 and missing revenue estimates by $13.6 million. Since the company's report, shares of Questcor Pharmaceuticals have risen from $79.05 to $87.34, representing a gain of 10.5% in the past 14 days.

Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce Early Termination of HSR Act Waiting Period
Business Wire - Mon May 12, 6:01AM CDT
Mallinckrodt plc (NYSE: MNK), and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR" , in connection with Mallinckrodt's proposed acquisition of Questcor, was terminated by the United States Federal Trade Commission on May 9, 2014.

Webcast Schedules, Clinical Study Results, Stock Price Movements, and Grants - Analyst Notes on Illumina, Questcor, Quest Diagnostics, Raytheon and Lockheed Martin
PR Newswire - Mon May 12, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Illumina Inc. (NASDAQ: ILMN), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Quest Diagnostics Inc. (NYSE: DGX), Raytheon Co. (NYSE: RTN) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2321-100free.

Scanning Equities that Reached New highs -- Research on Energy Transfer Equity, Questcor Pharma, Health Net, and Molson Coors Brewing
PR Newswire - Thu May 08, 12:30PM CDT
The markets on Wednesday, May 07, 2014 ended on a mixed note as the Dow Jones Industrial Average finished the day at 16,518.54, up 0.72%, and the NASDAQ Composite closed at 4,067.67, down 0.32%. The S&P 500 finished the session 0.56% higher at 1,878.21. The gains were broad based as eight out of ten sectors ended the session in positive. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include Energy Transfer Equity L.P. (NYSE: ETE), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Health Net Inc. (NYSE: HNT) and Molson Coors Brewing Company (NASDAQ: TAP). Free technical research on ETE, QCOR, HNT and TAP can be downloaded upon signing up at:

Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed
at Investor's Business Daily - Thu May 08, 10:19AM CDT
Canadian drugmaker Valeant Pharmaceuticals International (VRX) reported a mixed but mostly in-line Q1 Thursday, as management continued to press its case for a merger with Allergan (AGN). Valeant's stock rose fractionally on the stock market today....

Mallinckrodt plc Reports Fiscal 2014 Second Quarter Financial Results; Increases Full-Year 2014 Guidance
Business Wire - Thu May 08, 5:01AM CDT
--Increases guidance on full-year revenue and full-year adjusted diluted earnings per share reflecting strength of base business and acquisition of Cadence

After Yesterday's Rally of 2.53% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed May 07, 5:17PM CDT
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $83.51 to a high of $86.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $85.00 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Uptrend Call Working As Questcor Pharmaceuticals Stock Rises 28.1% (QCOR)
Comtex SmarTrend(R) - Wed May 07, 4:46PM CDT
SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on April 1st, 2014 at $67.41. In approximately 1 month, Questcor Pharmaceuticals has returned 28.13% as of today's recent price of $86.37.

Akorn Q1 EPS Beats, Raises Full-Year Profit Outlook
at Investor's Business Daily - Tue May 06, 11:11AM CDT
Specialty drugmaker Akorn (AKRX) on Tuesday reported first-quarter EPS above views, but revenue was light. The company also raised its full-year profit outlook. Lake Forest, Ill.-based Akorn said that it earned 16 cents per share in the three months...

Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
PR Newswire - Mon May 05, 8:00AM CDT
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from the first modern clinical study examining the use of H.P. Acthar® Gel (repository corticotropin injection) in systemic lupus erythematosus (SLE) has been published in the journal LUPUS. This independent investigator-initiated ten patient study was conducted at Fiechtner Research, a rheumatology research center, and evaluated the efficacy of Acthar in reducing SLE disease activity among patients who presented with moderately to severely active disease despite receiving traditional SLE maintenance treatments. Acthar is approved by the Food and Drug Administration (FDA) for 19 indications, including for use during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus.

Questcor CEO's Daughter Granted Huge Pay Raise
at The Street - Fri May 02, 11:20AM CDT
Her salary jumps to more than $1 million in 2013 from $300,000 in 2012, according to Questcor disclosure.

Awards, Stock Price Updates, Quarterly Earnings Releases, and Clinical Study Results - Analyst Notes on Aetna, Regeneron, Questcor, Medtronic and Lilly
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Aetna Inc. (NYSE: AET), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Medtronic Inc. (NYSE: MDT) and Eli Lilly & Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1903-100free.

Questcor Pharmaceuticals Up 20.4% Since SmarTrend Uptrend Call (QCOR)
Comtex SmarTrend(R) - Wed Apr 30, 11:05AM CDT
SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on April 1st, 2014 at $67.41. In approximately 4 weeks, Questcor Pharmaceuticals has returned 20.36% as of today's recent price of $81.14.

INVESTOR ALERT - Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt
Business Wire - Wed Apr 30, 10:55AM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Questcor Pharmaceuticals Inc. (NasdaqGS: QCOR) ("Questcor" in connection with the sale of the Company to Mallinckrodt.

Small-Cap Growth Stocks: On a Roll With Room to Run
Selena Maranjian, The Motley Fool - Motley Fool - Tue Apr 29, 4:17PM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small-cap growth stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Vanguard Russell 2000...

Questcor Misses on Earnings & Revs in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 10:40AM CDT
Questcor Pharmaceuticals reported first quarter 2014 earnings per share of $1.24, up from the year-ago earnings of $0.85 per share but missed the Zacks Consensus Estimate of $1.71.

QUESTCOR (QCOR) SHAREHOLDER ALERT - The Law firm of Andrews & Springer LLC Announces An Investigation of Questcor Pharmaceuticals, Inc.
PR Newswire - Mon Apr 28, 6:30PM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company" (NASDAQ: QCOR) relating to the sale of the Company to Mallinckrodt plc (NYSE: MNK) ("Mallinckrodt" . On April 7, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Mallinckrodt will acquire Questcor in a merger valued at roughly $5.6 billion. As a result of the merger, shareholders are anticipated to receive $30 in cash and .897 shares of Mallinckrodt for each share of Questcor stock.

Questcor Pharmaceuticals Set to Possibly Rebound After Yesterday's Selloff of 3.01%
Comtex SmarTrend(R) - Mon Apr 28, 4:32PM CDT
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $76.35 to a high of $82.53. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $76.75 on volume of 4.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Growth in Acthar Gel Pushes Questcor's Profits Up by 84% in Q1
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 28, 4:28PM CDT
It was just business as usual for Questcor Pharmaceuticals which delivered another quarter of phenomenal revenue and profit growth to begin 2014. For the first quarter, Questcor reported revenue of $227.1 million, a 68% increase from the...

Questcor Reports First Quarter Financial Results
PR Newswire - Mon Apr 28, 3:01PM CDT
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the first quarter ended March 31, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 92

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 48

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Why Insurance Must Change as Family Assets Keep Growing

Updated Category News Views 73

A policy bought in the starter-home years can turn stale quietly while everything around it gets bigger, pricier and more complicated. That is the uncomfortable little truth behind Daniel C. DiCocco's discussion in HelloNation: families often treat insurance as a box checked long ago, even as they add property, savings, debt, children and fresh responsibilities. Static...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 37

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 79

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 46

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading

Top 5 Most Recently Viewed Articles

Thompson Thrift Secures Over $255 Million in New Funding

Updated Category News Views 303

Thompson Thrift Closes Major Funding Round for Multifamily Developments Thompson Thrift, a well-known real estate company, recently announced a significant achievement in closing its 2025 multifamily development fund. This limited partnership offering successfully raised over $255 million in capital commitments, exceeding its original target of $230 million. The funds aim...

Continue Reading
Buyglobal's Summer Sale Offers Outdoor Essentials and Deals

Updated Category News Views 25

Buyglobal's Summer Event: A Sunny Boost for Backyard Living Summer's rolling in, and Buyglobal is gearing up to help you transform those backyard spaces into your very own oasis. This ain't your average sale event—this is Buyglobal jumping headfirst into the season with a curated lineup that's all about making the most of the outdoors. They rolled out their...

Continue Reading
Tony Fadell Champions Plumerai's Tiny AI for Smart Homes

Updated Category News Views 201

Transforming Smart Home Security with Tiny AI In the realm of innovative technology, Tony Fadell, co-creator of the iPod and Nest founder, recognizes the groundbreaking work Plumerai is doing in the field of artificial intelligence. Their emphasis on Tiny AI technology is heralded as a pivotal shift that aims to democratize AI for everyday use, particularly in smart home...

Continue Reading
Glenn Pushis Takes Action: Sells $172K in Steel Dynamics Shares

Updated Category News Views 183

Understanding Insider Actions at Steel Dynamics A notable insider transaction has come to light involving Glenn Pushis, the Senior Vice President at Steel Dynamics (NASDAQ: STLD). This transaction was detailed through an SEC filing that disclosed a significant sell-off of shares worth $172,043. Details of the Sell-Transaction According to the Form 4 filing submitted to...

Continue Reading
SCF Partners Strengthens Market Position with New Acquisition

Updated Category News Views 228

SCF Partners' Strategic Acquisition of Newpark Fluids Systems SCF Partners is making waves with its recent acquisition of Newpark Fluids Systems, a well-respected name in the oil, gas, and geothermal fluids industry. This strategic decision underscores SCF's dedication to broadening its service offerings and expanding its market presence. Newpark Fluids Systems has built...

Continue Reading